Prevalence and clinical manifestations of polycystic ovarian syndrome among adolescent and adult women in Davangere, Karnataka

Sapna I. S.; Gayathri L. Patil; Pooja H.; Vindhya M. Desai

doi:10.18203/2320-1770.ijrcog20261261

Authors

Sapna I. S. Department of Obstetrics and Gynecology, SS Institute of Medical Sciences and Research Centre, Davangere, Karnataka, India
Gayathri L. Patil Department of Obstetrics and Gynecology, SS Institute of Medical Sciences and Research Centre, Davangere, Karnataka, India
Pooja H. Department of Obstetrics and Gynecology, SS Institute of Medical Sciences and Research Centre, Davangere, Karnataka, India
Vindhya M. Desai Department of Obstetrics and Gynecology, SS Institute of Medical Sciences and Research Centre, Davangere, Karnataka, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20261261

Keywords:

PCOS, Adolescence, Acne, Hirsutism, Overweight, Obese

Abstract

Background: The prevalence of a disease in a particular region is always a necessary tool for any control measures. There are no full-fledged published data on PCOS prevalence and clinical manifestation patterns in our study setting geographic location. This study aimed to study the prevalence and clinical manifestation of PCOS among adolescents and adult women.

Methods: This is a prospective cross-sectional observational study conducted with total of 426 participants. A structured questionnaire was given to all the participants and collected data was assessed. Questionnaire included the following components; (i) Knowledge assessment, (ii) Anthropometric assessment, (iii) Clinical history, and (iv) Menstrual history included irregularity as well as presence of oligomenorrhea after one year of menarche, wait gain and hirsutism/ androgen production assessment (skin problems, and hair distribution).

Results: 27% of adolescent PCOS cases were found to be in the age group of 10-18 years. While, 11% of adult women with PCOS were found to be in the age group of 19-45 years. Majority of the study participants with PCOS were found to be obese (49.1%) followed be overweight (31.7%), and non-obese (19.2%) indicating an association of BMI with PCOS. Majority of the PCOS cases i.e., 37.3% were presented with acne/oily skin followed by alopecia (17.4%), mood swings/depression (16.8%), pigmentation (16.1%), and hirsutism (12.4%).

Conclusions: PCOS is increasingly encountered during adolescence with clinical manifestation of acne/oily skin in our study setting. Furthermore, PCOS was associated with overweight and obesity. Therefore, our study is indicative of the fact that all overweight and/or obese adolescence with acnes and/or oily skin should be screened for PCOS for early diagnosis and management.

Metrics

Metrics Loading ...

References

Franks S. Polycystic ovary syndrome in adolescents. Int J Obes (Lond). 2008;32(7):1035-41. DOI: https://doi.org/10.1038/ijo.2008.61

Azziz R, Dumesic DA, Goodarzi MO. Polycystic ovary syndrome: An ancient disorder? Fertil Steril. 2011;95(5):1544-8. DOI: https://doi.org/10.1016/j.fertnstert.2010.09.032

Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A, Abdollahi M. Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. Int J Mol Sci. 2022;23(2):583. DOI: https://doi.org/10.3390/ijms23020583

Laddad MM, Kshirsagar NS, Shinde GP, Shivade VS. Study of prevalence and determinants of polycystic ovarian syndrome among adolescent girls in rural area: a prospective study. Int J Reprod Contracept Obstet Gynecol. 2019;8(8):3135-9. DOI: https://doi.org/10.18203/2320-1770.ijrcog20193524

Khan MJ, Ullah A, Basit S. Genetic basis of polycystic ovary syndrome (PCOS): current perspectives. Appl Clin Genet. 2019;12:249-60. DOI: https://doi.org/10.2147/TACG.S200341

Desai NA, Tiwari RY, Patel SS. Prevalence of polycystic ovary syndrome and its associated risk factors among adolescent and young girls in Ahmedabad region. Ind J Pharm Pract.2018;11(3):119-25. DOI: https://doi.org/10.5530/ijopp.11.3.27

Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adol Gynecol. 2011;24(4):223-7. DOI: https://doi.org/10.1016/j.jpag.2011.03.002

Witchel SF, Oberfield SE, Pena AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls [presentation]. J Endocr Soc. 2019;3(8):1545-73. DOI: https://doi.org/10.1210/js.2019-00078

Saadia Z. Follicle stimulating hormone (LH: FSH) ratio in polycystic ovary syndrome (PCOS)-obese vs. non-obese women. Med Arch. 2020;74(4):289-93. DOI: https://doi.org/10.5455/medarh.2020.74.289-293

Christ JP, Cedars MI. Current Guidelines for Diagnosing PCOS. Diagnostics (Basel). 2023;13(6):1113. DOI: https://doi.org/10.3390/diagnostics13061113

Divya K, Mounisha B, Sowmya RV. Prevalence of polycystic ovarian syndrome among young women who attended tertiary care hospital, Visakhapatnam. Int J Curr Pharm Res. 2024;16 (4):75-8. DOI: https://doi.org/10.22159/ijcpr.2024v16i4.5026

Lyon CC. Acne: Diagnosis and Management. JR Soc Med. 2001;94(12):652. DOI: https://doi.org/10.1177/014107680109401221

Sutaria AH, Masood S, Saleh HM, Schlessinger J. Acne Vulgaris. 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.

Zouboulis CC. Acne as a chronic systemic disease. Clin Dermatol. 2014;32(3):389-96. DOI: https://doi.org/10.1016/j.clindermatol.2013.11.005

Ozdemir S, Ozdemir M, Gorkemli H, Kiyici A, Bodur S. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Acta Obstet Gynecol Scand. 2010;89(2):199-204. DOI: https://doi.org/10.3109/00016340903353284

Alan S, Cenesizoglu E. Effects of hyperandrogenism and high body mass index on acne severity in women. Saudi Med J. 2014;35(8):886-9. DOI: https://doi.org/10.15537/1658-3175.6019

Kansra AR. Polycystic ovary syndrome in adolescents. J Clin Out Manag. 2016;23(5):xx.

Kamboj MK, Bonny AE. Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies. Translational Pediatr. 2017;6(4):248. DOI: https://doi.org/10.21037/tp.2017.09.11

Singh A, Vijaya K, Laxmi KS. Prevalence of polycystic ovarian syndrome among adolescent girls: a prospective study. Int J Reprod Contracept Obstet Gynecol. 2018;7(11):4375-8. DOI: https://doi.org/10.18203/2320-1770.ijrcog20184230

Ganie MA, Rashid A, Sahu D, Nisar S, Wani IA, Khan J. Prevalence of polycystic ovary syndrome (PCOS) among reproductive age women from Kashmir valley: a cross-sectional study. Int J Gynaecol Obstet. 2020;149(2):231-6. DOI: https://doi.org/10.1002/ijgo.13125

Deswal R, Nanda S, Ghalaut VS, Roy PS, Dang AS. Cross-sectional study of the prevalence of polycystic ovary syndrome in rural and urban populations. Int J Gynaecol Obstet. 2019;146(3):370-9. DOI: https://doi.org/10.1002/ijgo.12893

Joseph N, Reddy AG, Joy D, Patel V, Santhosh P, Das S, Reddy SK. Study on the proportion and determinants of polycystic ovarian syndrome among health sciences students in South India. J Nat Sci Biol Med. 2016;7(2):166-72. DOI: https://doi.org/10.4103/0976-9668.184704

Joshi B, Mukherjee S, Patil A, Purandare A, Chauhan S, Vaidya R. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Ind J Endocrinol Metabol. 2014;18(3):317. DOI: https://doi.org/10.4103/2230-8210.131162

Batista, FAS, Paula A. Types of Acne and associated therapy. Am Research J. 2006; 15:257-66.

Emiroğlu N, Cengiz FP, Kemeriz F. Insulin resistance in severe acne vulgaris. Postepy Dermatol Alergol. 2015;32(4):281-5. DOI: https://doi.org/10.5114/pdia.2015.53047

Chandra M, Garg P, Vats K, Tibrewal A. An observational study on prevalence and determinants of PCOS in women presenting with acne vulgaris to a tertiary care hospital in North India. Int J Community Med Public Health. 2021;8:1270-5. DOI: https://doi.org/10.18203/2394-6040.ijcmph20210812

Raja SA, Prasad PVS, Kaviarasan PK. Prevalence and pattern of PCOS in women presenting with acne, a hospital based prospective observational study. Int J Res Med Sci. 2018;6(3):899-903. DOI: https://doi.org/10.18203/2320-6012.ijrms20180611

Zandi S, Farajzadeh S, Safari H. Prevalence of polycystic ovary syndrome in women with acne: hormone profiles and clinical findings. J Am Acad Dermatol. 2016;20(4):194-8.

Kelekci KH, Kelekci S, Incki K, Ozdemir O, Yilmaz B. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne. Int J Dermatol. 2010;49(7):775-9. DOI: https://doi.org/10.1111/j.1365-4632.2009.04389.x

Abdullah Z, Masood Q, Hassan I, Kirmani O. Hormonal profile and polycystic ovaries in women with acne vulgaris. Ind J Dermatol Venereol Leprol. 2013;79(3):422-4. DOI: https://doi.org/10.4103/0378-6323.110772

Maluki AH. The frequency of polycystic ovary syndrome in females with resistant acne vulgaris. J Cosmet Dermatol. 2010;9(2):142-8. DOI: https://doi.org/10.1111/j.1473-2165.2010.00500.x

Betti R, Bencini PL, Lodi A, Urbani CE, Chiarelli G, Crosti C. Incidence of polycystic ovaries in patients with late-onset or persistent acne: hormonal reports. Dermatologica. 1990;181(2):109-11. DOI: https://doi.org/10.1159/000247896

Tehrani M, Parvizi M, Moghadam AS, Heshmat R, Khas SNZ, Golchin M. The prevalence of polycystic ovary syndrome in Iranian women with gestational diabetes: a pilot study. Iranian J Diab Lipid Disorders. 2009:57-64.

Falsetti L, Gambera A, Andrico S, Sartori E. Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences. Gynecol Endocrinol. 2002;16(4):275-84. DOI: https://doi.org/10.1080/713603096

Lee AT, Zane LT. Dermatologic manifestations of polycystic ovary syndrome. Am J Clin Dermatol. 2007;8(4):201-19. DOI: https://doi.org/10.2165/00128071-200708040-00003

Yu NE, Ho PC. Polycystic ovary syndrome in Asian women. Semin Reprod Med. 2008;26(1):14-21. DOI: https://doi.org/10.1055/s-2007-992920